GB202201069D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB202201069D0
GB202201069D0 GBGB2201069.8A GB202201069A GB202201069D0 GB 202201069 D0 GB202201069 D0 GB 202201069D0 GB 202201069 A GB202201069 A GB 202201069A GB 202201069 D0 GB202201069 D0 GB 202201069D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2201069.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Excalibur Medicines Ltd
Original Assignee
St George Street Capital Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St George Street Capital Ltd filed Critical St George Street Capital Ltd
Priority to GBGB2201069.8A priority Critical patent/GB202201069D0/en
Publication of GB202201069D0 publication Critical patent/GB202201069D0/en
Priority to PCT/GB2022/052354 priority patent/WO2023041927A1/en
Ceased legal-status Critical Current

Links

GBGB2201069.8A 2021-09-16 2022-01-27 Treatment Ceased GB202201069D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2201069.8A GB202201069D0 (en) 2022-01-27 2022-01-27 Treatment
PCT/GB2022/052354 WO2023041927A1 (en) 2021-09-16 2022-09-16 Azd1656 for use in the treatment of pneumonitis or myocarditis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2201069.8A GB202201069D0 (en) 2022-01-27 2022-01-27 Treatment

Publications (1)

Publication Number Publication Date
GB202201069D0 true GB202201069D0 (en) 2022-03-16

Family

ID=80621193

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2201069.8A Ceased GB202201069D0 (en) 2021-09-16 2022-01-27 Treatment

Country Status (1)

Country Link
GB (1) GB202201069D0 (en)

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202319954D0 (en) Treatment
GB202319658D0 (en) Treatment
GB202319443D0 (en) Treatment
GB202318845D0 (en) Treatment
GB202311007D0 (en) Treatment
GB202304853D0 (en) Treatment
GB202218460D0 (en) Treatment
GB202214206D0 (en) Treatment
GB202212125D0 (en) Treatment
GB202204288D0 (en) Treatment
GB202204070D0 (en) Treatment
GB202201069D0 (en) Treatment
GB202212566D0 (en) Combination treatment
GB202304716D0 (en) New treatment
GB202210430D0 (en) New treatment
GB202206219D0 (en) New treatment
GB202208508D0 (en) Novel treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202103122D0 (en) Treatment

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: EXCALIBUR MEDICINES LIMITED

Free format text: FORMER OWNER: ST GEORGE STREET CAPITAL LIMITED

AT Applications terminated before publication under section 16(1)